Association between maternal country of birth and psychotropic medication use at age 18, unadjusted (model 1) and adjusted (model 2) for the risk score (RS) for psychotropic medication use*
| Boys | Girls | |||||||
|---|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 1 | Model 2 | |||||
| OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
| Maternal country of birth | ||||||||
| Sweden | Reference | Reference | Reference | Reference | ||||
| High-income country | 1.08 | (0.96 to 1.21) | 1.01 | (0.90 to 1.13) | 1.08 | (0.99 to 1.19) | 1.03 | (0.94 to 1.13) |
| Upper middle-income country | 0.94 | (0.80 to 1.10) | 0.80 | (0.69 to 0.94) | 0.74 | (0.64 to 0.85) | 0.66 | (0.57 to 0.76) |
| Lower middle-income country | 0.90 | (0.75 to 1.07) | 0.78 | (0.66 to 0.94) | 0.59 | (0.50 to 0.70) | 0.53 | (0.45 to 0.63) |
| Low-income country | 0.69 | (0.48 to 0.98) | 0.57 | (0.40 to 0.82) | 0.32 | (0.21 to 0.48) | 0.28 | (0.19 to 0.42) |
| Risk score (RS) for psychotropic drug use* | ||||||||
| First quartile | Reference | Reference | ||||||
| Second quartile | 1.17 | (1.01 to 1.29) | 1.10 | (1.04 to 1.21) | ||||
| Third quartile | 1.45 | (1.32to 1.59) | 1.31 | (1.13 to 1.31) | ||||
| Fourth quartile | 2.55 | (2.34 to 2.77) | 1.81 | (1.81 to 2.01) | ||||
Values are OR and 95% CI.
*Variables included in the RS for psychotropic drug use: Perinatal period (Apgar score, child's birth year, maternal smoking during pregnancy, maternal age, maternal educational level, family situation); Infancy, Childhood and Adolescence (extensive hospitalisation child, psychiatric diagnosis child, extensive hospitalisation mother and psychiatric diagnosis mother).